CometReports
  • Home
  • Morning Updates
  • Earnings Outlook
  • Analysts Ratings
  • Stocks Review
No Result
View All Result
  • Home
  • Morning Updates
  • Earnings Outlook
  • Analysts Ratings
  • Stocks Review
No Result
View All Result
CometReports
No Result
View All Result

Diversified Healthcare Trust (DHC) Down -52.44% From Its 52-Week High, But Growth Potential Is Changing Over Time

Ginger Baker by Ginger Baker
March 17, 2023
in Technology and Energy
0

Diversified Healthcare Trust (NASDAQ:DHC) currently has a daily average trading volume of 5.04M but it saw 2402829 shares traded on Thursday. With a market cap of 438.67M USD, stock’s current market price of $1.56 came rising about 1.96 while comparing to the previous closing price of $1.53. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.28 and as low as $0.61. In the recent trading on the day, stock has struck highest price mark of $1.60 while lowest mark touched by it was $1.48.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.

Sponsored

Taking a look at 20-day trading activity of Diversified Healthcare Trust (DHC) gives us an average price of $1.3011, while its current price level is -52.44% below from 52-week high level whereas it is 155.74% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.9640 while that of 200 days or SMA-200 reads an average of $1.2864. A closer look into the stock’s movement over the week reveals that its volatility is standing at 10.08% during that period while stretching the period over a month that increases to 13.50%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 62.72 which implies that the stock is in neutral territory.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which downgraded the stock as “Underweight” in its note to investors issued on December 10, 2020, recommending a price target of $4 for it. Wells Fargo also issued its recommendations for the stock as it downgraded the price target for the stock is $9.

Over the week, DHC’s stock price is moving -11.36% down while it is 140.37% when we observe its performance for the past one month. Year-to-date it is 141.19% up and over the past year, the stock is showing a downside performance of -49.35%.

The latest quarterly earnings report issued by the company was for quarter ended 9/29/2022, when its quarterly earnings per share (EPS) of -$0.34 beaten by the consensus estimate of -$0.24 for the same. The company is expected to be releasing its next quarterly report in 05/11/2023, for which analysts forecasted an EPS of -$0.26 while estimate for next year EPS is $0. In next quarter, company is expected to be making quarterly sales of $334.79 million as analysts are expecting the sales for current fiscal year at $1.28 billion and seeing the company making $1.37 billion in sales next year. Moreover, analysts are in estimates of $330.14 million for current-quarter revenue.

Currently, Diversified Healthcare Trust’s total number of outstanding shares is 238.56M with 1.36% of that held by the insiders while 81.60% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -2.20% and return on equity (ROE) at -0.60%. Stock’s beta reads 1.62. Stock has a price to book (P/B) ratio of 0.14 while price to sale or P/S ratio amounts to 0.34. Its return on asset (ROA) is -0.30% on average.

A filing at the U.S. Securities and Exchange Commission revealed that Vanguard Real Estate Index Fund came shrinking its share ownership by -0.32% in the Diversified Healthcare Trust (DHC) decreasing its stake to 4.47% with control over 34430.0 shares in the company. As per SEC documents, Vanguard Real Estate Index Fund sought 10,716,655 of company’s common stock of worth $10.5 million as per recent closing price of the stock. Vanguard Real Estate Index Fund is not the only institutional holder which restructured its stake in Diversified Healthcare Trust, as Vanguard Total Stock Market Index picked 6,783,759 shares of worth $6.65 million to bring its holdings to a total of 0.36 million shares. In the most recent quarter, iShares Russell 2000 ETF came cutting its stake by -0.32% in the company and now holds 5.34 million or 2.23% of the company’s stake having worth of about 5.23 million.

Tags: DHCDHC stockDiversified Healthcare TrustNASDAQ:DHC
Previous Post

Look Past The Setbacks And Give Silvergate Capital Corporation (NYSE: SI) Another Chance

Next Post

Should You Sell The Bank of Nova Scotia (BNS) And Go Away This Year?

Ginger Baker

Ginger Baker

Next Post

Should You Sell The Bank of Nova Scotia (BNS) And Go Away This Year?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

Should You Sell RAPT Therapeutics Inc. (RAPT) And Go Away This Year?

March 31, 2023

Tronox Holdings plc (NYSE: TROX) Bulls Still Eyeing Towards $27.00

March 31, 2023

Virtu Financial Inc. (VIRT) Down -51.57% From Its 52-Week High, But Growth Potential Is Changing Over Time

March 31, 2023

Prosperity Bancshares Inc. (NYSE: PB) Recovers 4.33% From 52-Week Low, Is PB Still A High-Risk, High-Reward Play?

March 31, 2023

ABOUT US
Become an active part of this community! We will be happy about any activity related to the transfer of your information experience. Write stories about your travels, share opinions about cities, countries and places of interest. Get answers to any questions related to news, scientific projects, travel and other things, and answer them yourself.

Categories

  • Morning Updates
  • Earnings Outlook
  • Analysts Ratings
  • Stocks Review
  • Business
  • Technology and Energy

Company

  • Home
  • About us
  • Contact Us

Recent Posts

  • Should You Sell RAPT Therapeutics Inc. (RAPT) And Go Away This Year?
  • Tronox Holdings plc (NYSE: TROX) Bulls Still Eyeing Towards $27.00
  • Virtu Financial Inc. (VIRT) Down -51.57% From Its 52-Week High, But Growth Potential Is Changing Over Time

Copyright © 2022 Comet Reports

No Result
View All Result
  • About us
  • Contact Us
  • Home

Copyright © 2022 Comet Reports